The pharmaceutical and oncological testing of new drugs or treatment concepts for cancer is a specialized market segment. Using the equipment available, all experimental techniques can be carried out in first-rate quality. That means that EPO is an attractive partner for the drug development section of large pharmaceutical companies, for partners from the Biotech industry and for research institutions.

Segments

Rote Biotechnologie, Rote Biotechnologie - Medikamente und Drug Delivery, Rote Biotechnologie - Technologie und Dienstleistungen für Medikamentenentwicklung, Rote Biotechnologie - Tissue Engineering und Regenerative Medizin, Diagnostik